• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

CE Mark

Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

October 22, 2026 By Jim Hammerand

The Teleflex Freesolve RMS (resorbable magnesium scaffold).

The Teleflex (NYSE: TFX) Freesolve RMS (resorbable magnesium scaffold) has won FDA Breakthrough Device designation for percutaneous coronary intervention (PCI). "Freesolve RMS has the potential to provide physicians with an additional treatment option, by reducing the need for permanent implants and potentially offering an alternative to … [Read more...] about Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold

Filed Under: Advanced Materials, Applications, Cardiac Implants, Cardiology, CE Mark, Coatings, Components, FDA Breakthrough Designation, Implants, Product Development, Regulatory, Research & Development, Technologies & Devices Tagged With: bioabsorbable polymers, biotronik, cardiovascular, drug-eluting stents, resorbable, teleflex

Medtronic says Endurant stent graft’s new CE mark could boost use for ruptured AAA

September 4, 2026 By Chris Newmarker

The Endurant stent graft system. [Image courtesy of Medtronic]

Medtronic (NYSE: MDT) has secured a CE mark for its Endurant stent graft, removing a treatment warning related to its use in ruptured abdominal aortic aneurysms (AAA). The Minnesota-run medtech giant received a similar FDA labeling change in late 2025. A ruptured AAA occurs when the main artery in the abdomen bursts, causing severe internal … [Read more...] about Medtronic says Endurant stent graft’s new CE mark could boost use for ruptured AAA

Filed Under: Applications, Cardiology, CE Mark, Regulatory, Stents Tagged With: medtronic

Medtronic wins expanded indication in Europe for Affera to treat VT

August 6, 2026 By Chris Newmarker

A sphere-shaped, expandable lattice device with electrodes for cardiac ablation

Medtronic (NYSE: MDT) has won an expanded CE mark indication for its Affera mapping and ablation system with Sphere-9 catheter to treat ventricular arrhythmias. The expanded indication, announced today, includes ventricular tachycardia (VT) and premature ventricular complexes (PVCs). According to Medtronic, the Sphere-9 catheter is the first … [Read more...] about Medtronic wins expanded indication in Europe for Affera to treat VT

Filed Under: Applications, Cardiology, CE Mark, FDA Breakthrough Designation, Pulsed Field Ablation, Regulatory, Technologies & Devices Tagged With: medtronic

Galaxy Therapeutics’ SEAL embolization system gets CE mark 

August 4, 2026 By MT+E Staff

This is a Galaxy Therapeutics illustration of the SEAL embolization system in action.

By Julia Rock-Torcivia Galaxy Therapeutics, a privately held medical device company focused on the treatment of intracranial aneurysms, today announced that it has received CE mark for its SEAL Embolization System. The CE mark follows successful assessment by Notified Body DQS Medizinprodukte GmbH.  SEAL (which stands for Saccular … [Read more...] about Galaxy Therapeutics’ SEAL embolization system gets CE mark 

Filed Under: Applications, Catheters, CE Mark, Neurology, Regulatory Tagged With: Galaxy Therapeutics, nitinol

Penumbra earns CE mark for Thunderbolt thrombectomy system

June 15, 2026 By Sean Whooley

Penumbra Thunderbolt computer-assisted vacuum thrombectomy technology

Penumbra (NYSE:PEN) announced today that it received CE mark approval for its Thunderbolt thrombectomy system for stroke. European approval for the computer-assisted vacuum thrombectomy (CAVT) technology comes just days after FDA clearance. Thunderbolt expands the company’s computer-assisted vacuum thrombectomy (CAVT) portfolio. It aims to … [Read more...] about Penumbra earns CE mark for Thunderbolt thrombectomy system

Filed Under: Applications, Catheters, CE Mark, Neurology, Regulatory, Technologies & Devices Tagged With: penumbra

Gore wins CE mark for Fortegra venous stent

June 9, 2026 By Sean Whooley

Gore Viabahn Fortegra venous stent

W.L. Gore & Associates announced today that it received CE mark approval for its Viabahn Fortegra venous stent system. European approval comes about six months after the stent picked up FDA approval. The company labeled Viabahn Fortegra the first device for the treatment of deep venous disease in the inferior vena cava (IVC), iliac and … [Read more...] about Gore wins CE mark for Fortegra venous stent

Filed Under: Catheters, CE Mark, Materials, Nitinol, Regulatory, Stents, Technologies & Devices Tagged With: gore, nitinol, W.L. Gore & Associates

BD picks up CE mark for next-gen stent graft

April 8, 2026 By Sean Whooley

BD Liverty TIPS stent graft for portal hypertension

BD (NYSE:BDX) announced today that it received CE mark approval for its Liverty TIPS stent graft system. Franklin Lakes, New Jersey-based BD designed the stent graft to expand treatment options for patients with cirrhosis and complications of portal hypertension. The next-generation, adjustable-diameter device marks the latest advancement for … [Read more...] about BD picks up CE mark for next-gen stent graft

Filed Under: Applications, Cardiac Implants, Cardiology, CE Mark, Regulatory, Stents, Technologies & Devices Tagged With: BD

Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe

April 7, 2026 By Sean Whooley

Johnson & Johnson Varipulse Pro pulsed field ablation PFA catheter

Johnson & Johnson (NYSE:JNJ) announced today that it launched the Varipulse Pro system in Europe following CE mark approval. Varipulse Pro features a new pulse sequence that marks the next evolution of the pulsed field ablation (PFA) platform. The company said it designed the technology to improve procedural efficiency while reinforcing … [Read more...] about Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe

Filed Under: Applications, Cardiology, Catheters, CE Mark, Pulsed Field Ablation, Regulatory, Technologies & Devices Tagged With: Johnson & Johnson, johnson & johnson medtech

MicroPort EP wins European approval for PFA catheter

April 3, 2026 By Sean Whooley

MicroPort EP PulseMagic pulsed field ablation (PFA) catheter

MicroPort EP announced today that it received EU MDR certification for its PulseMagic pulsed field ablation (PFA) catheter. The China-based company designed its PFA catheter to enhance both flexibility and performance in electrophysiology (EP) procedures. MicroPort says that PulseMagic enables both high-density mapping and PFA through one … [Read more...] about MicroPort EP wins European approval for PFA catheter

Filed Under: Applications, Cardiology, Catheters, CE Mark, Pulsed Field Ablation, Regulatory, Technologies & Devices Tagged With: MicroPort, MicroPort EP

BD picks up CE mark for Revello vascular covered stent

March 5, 2026 By Sean Whooley

BD Revello Covered Stent CE mark (1) (1)

BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system. Franklin Lakes, New Jersey–based BD designed Revello to treat atherosclerotic lesions in the common and external iliac arteries. The next-generation endovascular solution combines the flexibility of a nitinol self-expanding stent with … [Read more...] about BD picks up CE mark for Revello vascular covered stent

Filed Under: Applications, Cardiology, CE Mark, Materials, Nitinol, Regulatory, Stents, Technologies & Devices Tagged With: BD, nitinol

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | RSS